AKTIS ONCOLOGY INC (AKTS) Institutional Ownership Changes & 13F Activity
AKTIS ONCOLOGY INC (AKTS). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q3 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Mpm Bioimpact Llc, Ecor1 Capital, Llc, T. Rowe Price Investment Management, Inc., Wellington Management Group Llp, and Rtw Investments, Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Versant Capital Management, Inc | Buy | +324 | — | 324 | $6.31K | Q3 2026 | Oct 02, 2026 |
| State Street Corp | Sell | -484,010 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 22, 2026 |
| Manufacturers Life Insurance Company, The | Sell | -48,044 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 09, 2026 |
| Citadel Advisors Llc | Sell | -25,537 | -100.0% | 0 | $0.00 | Q3 2026 | Sep 02, 2026 |
| California State Teachers Retirement System | Sell | -288 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 24, 2026 |
| Mpm Bioimpact Llc | Sell | -4,835,872 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Ecor1 Capital, Llc | Sell | -4,824,469 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | Sell | -2,051,447 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Wellington Management Group Llp | Sell | -1,966,244 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Rtw Investments, Lp | Sell | -1,592,043 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Ra Capital Management, L.P. | Sell | -1,314,405 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Baker Bros. Advisors Lp | Sell | -996,351 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Octagon Capital Advisors Lp | Sell | -960,847 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Price T Rowe Associates Inc | Sell | -763,499 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Tcg Crossover Management, Llc | Sell | -696,560 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Eventide Asset Management, Llc | Sell | -507,000 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Avidity Partners Management Lp | Sell | -484,200 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| A16Z Capital Management, L.L.C. | Sell | -415,000 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Alyeska Investment Group, L.P. | Sell | -290,000 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Charles Schwab Investment Management Inc | Sell | -166,842 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Barclays Plc | Sell | -151,696 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Soros Fund Management Llc | Sell | -100,000 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Woodline Partners Lp | Sell | -100,000 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Bank Of America Corp | Sell | -72,835 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Raymond James Financial Inc | Sell | -50,464 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Aqr Capital Management Llc | Sell | -48,123 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Sell | -38,381 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Sofinnova Investments, Inc. | Sell | -32,436 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Two Sigma Investments, Lp | Sell | -30,914 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
| Readystate Asset Management Lp | Sell | -30,000 | -100.0% | 0 | $0.00 | Q3 2026 | Aug 14, 2026 |
Frequently asked questions about AKTS activity
Which institutional owners are buying AKTS?
Institutional owners buying AKTS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in AKTS activity?
"Buy" means an investor increased their reported position in AKTS compared to the prior reporting period. This reflects growing exposure to AKTIS ONCOLOGY INC (AKTS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in AKTS increasing?
Institutional interest in AKTS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.